I-MED Pharma’s I-PEN® Receives Regulatory Approval from INVIMA in Colombia and ANMAT in Argentina MONTREAL, April 03, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian Company specializing in dry eye diagnosis and management, is pleased to announce receiving regulatory approval from INVIMA...

I-MED Pharma's I-PEN® Does Not Infringe the TearLab Patent MONTREAL, Feb. 20, 2018 (GLOBE NEWSWIRE) -- On February 14th TearLab issued a press release indicating it will appeal after its defeat in a patent infringement action against I-MED Pharma Inc. in...

I-MED Pharma partners with OCuSOFT to bring the I-PEN® Osmolarity System to the U.S.A. MONTREAL, Jan. 08, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with...